Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17201-17250 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03523377
Overnight Fasting After Completion of Therapy: The OnFACT Study
NA
Active, not recruiting
28 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
1 location
NCT03389477
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
26 participants
Started: Apr 27, 2018 · Completed: Apr 6, 2027
1 condition
2 sponsors
1 location
NCT03535831
PSMA PET Registry (18F-DCFPyL)
NA
Active, not recruiting
200 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03419234
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
PHASE2
Active, not recruiting
223 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
5 conditions
2 sponsors
672 locations
NCT03282409
Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit
N/A
Active, not recruiting
425 participants
Started: Apr 26, 2018 · Completed: May 31, 2025
2 conditions
1 sponsor
1 location
NCT03519997
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
PHASE2
Active, not recruiting
35 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT03392324
PRIMA US-Feasibility Study in Atrophic Dry AMD
NA
Active, not recruiting
5 participants
Started: Apr 26, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT03467867
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
PHASE2
Active, not recruiting
25 participants
Started: Apr 26, 2018 · Completed: Jan 31, 2026
1 condition
2 sponsors
2 locations
NCT03544736
Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Apr 26, 2018 · Completed: Dec 31, 2040
1 condition
2 sponsors
1 location
NCT03559036
Pediatric Locomotor Training Bladder Study
N/A
Active, not recruiting
6 participants
Started: Apr 26, 2018 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT03519451
Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment
NA
Active, not recruiting
24 participants
Started: Apr 25, 2018 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT03556280
Multi-Center Study of Sensory Stimulation to Improve Brain Function
NA
Active, not recruiting
60 participants
Started: Apr 24, 2018 · Completed: Sep 30, 2021
10 conditions
1 sponsor
5 locations
NCT03500380
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
PHASE2/PHASE3
Active, not recruiting
301 participants
Started: Apr 24, 2018 · Completed: Dec 31, 2024
6 conditions
1 sponsor
67 locations
NCT03525262
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)
PHASE2
Active, not recruiting
124 participants
Started: Apr 24, 2018 · Completed: Apr 30, 2029
1 condition
2 sponsors
8 locations
NCT03505801
Confirm Rx Insertable Cardiac Monitor SMART Registry
N/A
Active, not recruiting
1,826 participants
Started: Apr 24, 2018 · Completed: Mar 31, 2026
3 conditions
1 sponsor
112 locations
NCT03438747
P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation
NA
Active, not recruiting
290 participants
Started: Apr 24, 2018 · Completed: Feb 28, 2028
1 condition
1 sponsor
34 locations
NCT03245593
Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder
N/A
Active, not recruiting
300 participants
Started: Apr 24, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
16 locations
NCT03341520
Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
PHASE2
Active, not recruiting
89 participants
Started: Apr 24, 2018 · Completed: May 31, 2024
4 conditions
2 sponsors
12 locations
NCT03417297
A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy
NA
Active, not recruiting
10 participants
Started: Apr 24, 2018 · Completed: May 31, 2028
2 conditions
2 sponsors
1 location
NCT03530397
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
PHASE1
Active, not recruiting
401 participants
Started: Apr 24, 2018 · Completed: Dec 30, 2025
1 condition
1 sponsor
40 locations
NCT03423160
A Novel Framework for Impaired Imitation in ASD
N/A
Active, not recruiting
201 participants
Started: Apr 24, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03422848
Hydration to Optimize Metabolism
NA
Active, not recruiting
760 participants
Started: Apr 24, 2018 · Completed: Jun 30, 2025
1 condition
3 sponsors
1 location
NCT03425643
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
PHASE3
Active, not recruiting
797 participants
Started: Apr 24, 2018 · Completed: Jun 29, 2026
1 condition
1 sponsor
227 locations
NCT03456063
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
PHASE3
Active, not recruiting
453 participants
Started: Apr 24, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
117 locations
NCT03337360
The Impact of a Nutritional Supplement (Impryl®) on Male Fertility
NA
Active, not recruiting
1,200 participants
Started: Apr 23, 2018 · Completed: Apr 30, 2026
1 condition
2 sponsors
21 locations
NCT03481738
Pyruvate Kinase Deficiency Global Longitudinal Registry
N/A
Active, not recruiting
500 participants
Started: Apr 23, 2018 · Completed: May 31, 2027
1 condition
1 sponsor
52 locations
NCT05155423
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
N/A
Active, not recruiting
21 participants
Started: Apr 21, 2018 · Completed: May 24, 2026
1 condition
2 sponsors
1 location
NCT02732704
THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study
NA
Active, not recruiting
100 participants
Started: Apr 20, 2018 · Completed: Sep 29, 2027
1 condition
1 sponsor
19 locations
NCT03496402
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)
NA
Active, not recruiting
600 participants
Started: Apr 20, 2018 · Completed: Aug 19, 2027
6 conditions
1 sponsor
30 locations
NCT03495011
MRI Characterization of Mammographically Detected DCIS
N/A
Active, not recruiting
122 participants
Started: Apr 20, 2018 · Completed: Apr 30, 2032
1 condition
3 sponsors
1 location
NCT03493178
Glutathione in Mild Cognitive Impairment
EARLY_PHASE1
Active, not recruiting
60 participants
Started: Apr 19, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03475108
Integrating Community Health Workers Into the Care of Children With Type 1 Diabetes
NA
Active, not recruiting
84 participants
Started: Apr 19, 2018 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT03333356
Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)
NA
Active, not recruiting
81 participants
Started: Apr 19, 2018 · Completed: Dec 31, 2027
1 condition
1 sponsor
17 locations
NCT06841510
Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease
N/A
Active, not recruiting
1,118 participants
Started: Apr 19, 2018 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT03482791
Proton Beam Therapy in the Treatment of Esophageal Cancer
NA
Active, not recruiting
22 participants
Started: Apr 19, 2018 · Completed: Aug 9, 2026
3 conditions
1 sponsor
1 location
NCT03255746
HELP-HY: Health Education and sLeep Program in HYpertension
NA
Active, not recruiting
110 participants
Started: Apr 19, 2018 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03383458
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
PHASE3
Active, not recruiting
545 participants
Started: Apr 18, 2018 · Completed: Dec 16, 2025
2 conditions
2 sponsors
184 locations
NCT03330821
Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
PHASE1/PHASE2
Active, not recruiting
53 participants
Started: Apr 18, 2018 · Completed: Oct 16, 2026
3 conditions
2 sponsors
5 locations
NCT06874725
Latent Tuberculosis in Type 2 Diabetes
PHASE4
Active, not recruiting
552 participants
Started: Apr 18, 2018 · Completed: Apr 18, 2025
1 condition
1 sponsor
1 location
NCT03409016
Biomarkers of Immune-Related Toxicity
N/A
Active, not recruiting
69 participants
Started: Apr 18, 2018 · Completed: May 28, 2026
2 conditions
2 sponsors
1 location
NCT03493685
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
PHASE3
Active, not recruiting
371 participants
Started: Apr 17, 2018 · Completed: Feb 28, 2026
1 condition
1 sponsor
225 locations
NCT03611686
Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
N/A
Active, not recruiting
219 participants
Started: Apr 17, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT03348995
The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration
NA
Active, not recruiting
250 participants
Started: Apr 17, 2018 · Completed: Apr 17, 2034
2 conditions
1 sponsor
11 locations
NCT03462719
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
PHASE3
Active, not recruiting
211 participants
Started: Apr 17, 2018 · Completed: Apr 5, 2029
1 condition
2 sponsors
87 locations
NCT05582447
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
N/A
Active, not recruiting
40 participants
Started: Apr 17, 2018 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03213652
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
PHASE2
Active, not recruiting
13 participants
Started: Apr 17, 2018 · Completed: Oct 3, 2026
33 conditions
2 sponsors
126 locations
NCT03367741
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
PHASE2
Active, not recruiting
82 participants
Started: Apr 16, 2018 · Completed: Jul 23, 2026
5 conditions
1 sponsor
34 locations
NCT03564275
Proton Boost in Prostate Cancer
NA
Active, not recruiting
10 participants
Started: Apr 16, 2018 · Completed: Apr 30, 2033
1 condition
1 sponsor
1 location
NCT03316560
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
PHASE1/PHASE2
Active, not recruiting
29 participants
Started: Apr 16, 2018 · Completed: Mar 31, 2025
1 condition
1 sponsor
4 locations
NCT03478488
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
PHASE3
Active, not recruiting
480 participants
Started: Apr 16, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
342
343
344
345
346
347
348
More pages
431
Next